[
    {
        "title": "Burmester GR. Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial. Annals of the Rheumatic Diseases. 2016;75(6):1081.",
        "paper_uid": "5fc10a78",
        "reference": "Burmester GR. Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial. Annals of the Rheumatic Diseases. 2016;75(6):1081.",
        "save_folder_path": null,
        "study_design": "Randomized Controlled Trial"
    },
    {
        "title": "Campbell LC, C.; Bhagat, S. S.; Parker, R. A.; Ostor, A. J. K. Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials. Rheumatology (Oxford academic). 2010;50(3):552-62.",
        "paper_uid": "286647a1",
        "reference": "Campbell LC, C.; Bhagat, S. S.; Parker, R. A.; Ostor, A. J. K. Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials. Rheumatology (Oxford academic). 2010;50(3):552-62.",
        "save_folder_path": null,
        "study_design": "SYSTEMATIC_REVIEW"
    }
]